A detailed history of Cooper Financial Group transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Cooper Financial Group holds 6,291 shares of EW stock, worth $470,629. This represents 0.06% of its overall portfolio holdings.

Number of Shares
6,291
Previous 6,382 1.43%
Holding current value
$470,629
Previous $589,000 29.54%
% of portfolio
0.06%
Previous 0.09%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$59.7 - $93.78 $5,432 - $8,533
-91 Reduced 1.43%
6,291 $415,000
Q2 2024

Jul 15, 2024

BUY
$84.3 - $94.31 $180,233 - $201,634
2,138 Added 50.38%
6,382 $589,000
Q1 2024

Apr 11, 2024

BUY
$72.54 - $95.56 $145 - $191
2 Added 0.05%
4,244 $405,000
Q4 2023

Jan 16, 2024

BUY
$61.71 - $77.76 $30,361 - $38,257
492 Added 13.12%
4,242 $323,000
Q3 2023

Oct 13, 2023

BUY
$69.28 - $93.38 $259,800 - $350,175
3,750 New
3,750 $259,000
Q4 2022

Jan 13, 2023

SELL
$68.3 - $87.44 $273 - $349
-4 Reduced 0.11%
3,690 $0
Q3 2022

Oct 13, 2022

SELL
$82.37 - $107.29 $6,836 - $8,905
-83 Reduced 2.2%
3,694 $305,000
Q2 2022

Jul 11, 2022

BUY
$86.5 - $128.27 $7,525 - $11,159
87 Added 2.36%
3,777 $359,000
Q4 2021

Feb 11, 2022

SELL
$106.37 - $130.68 $80,096 - $98,402
-753 Reduced 16.95%
3,690 $478,000
Q2 2021

Jul 12, 2021

BUY
$83.84 - $104.76 $55,585 - $69,455
663 Added 17.54%
4,443 $460,000
Q4 2020

Feb 16, 2021

BUY
$71.69 - $91.23 $20,790 - $26,456
290 Added 8.31%
3,780 $345,000
Q3 2020

Oct 09, 2020

SELL
$67.19 - $87.44 $49,653 - $64,618
-739 Reduced 17.47%
3,490 $279,000
Q2 2020

Jul 15, 2020

BUY
$57.54 - $76.95 $243,336 - $325,421
4,229 New
4,229 $292,000
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $68,237 - $105,462
-1,302 Closed
0 $0
Q4 2019

Jan 07, 2020

BUY
$71.7 - $82.09 $430 - $492
6 Added 0.46%
1,302 $304,000
Q3 2019

Oct 08, 2019

BUY
$61.55 - $75.43 $5,724 - $7,014
93 Added 7.73%
1,296 $285,000
Q1 2019

May 15, 2019

BUY
$47.89 - $64.05 $57,611 - $77,052
1,203 New
1,203 $230,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Cooper Financial Group Portfolio

Follow Cooper Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Cooper Financial Group with notifications on news.